The Mass General Spinal Muscular Atrophy (SMA) Multidisciplinary Clinic provides the latest treatments and research opportunities for people with Spinal Muscular Atrophy.

Management Strategies:

Find information, guides and more resources on each of the following topics to aid you in planning a SMA management strategy:

• Respiratory

• Nutrition

• Exercise & Mobility

• Orthopedic

• Special Considerations in SMA Infants

• Dental Care

The first medication for SMA, Spinraza (Nusinersen), was approved by the FDA in December 2016. We’re here to help answer any questions you may have about this new treatment for SMA. Other than Spinraza, medical care is primarily supportive, focused on respiratory support, nutritional support, and musculoskeletal management.